Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myrciaria dubia is an Amazonian evergreen shrub whose fruit is commonly known as "camu camu." The fruit is notable for its extremely high vitamin C content and a rich profile of bioactive compounds including phenolic acids (such as ellagic acid), flavonoids (like rutin and quercetin), anthocyanins (cyanidin-3-glucoside), carotenoids (β-carotene, lutein), and various minerals. Traditionally used to address malnutrition due to its nutrient density, it has also been investigated for antioxidant, anti-inflammatory, antinociceptive (pain-relieving), antiedematogenic (anti-swelling), anti-allergic effects via mast cell stabilization and histamine receptor inhibition[1][2][3][5][7][9]. Its mechanism of action appears to be multifactorial—primarily through antioxidant activity attributed to vitamin C and polyphenols; some studies suggest direct inhibition of histamine H1/H4 receptors and histidine decarboxylase[9]. It is being explored in early clinical trials for potential roles in cancer therapy support and other chronic diseases but lacks robust evidence or regulatory approval for any specific indication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myrciaria dubia.